Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
genetic test
MedTech
Genetic test results harder to handle under new abortion rules
Texas' law virtually bans all abortions after six weeks. But prenatal tests can't diagnose genetic conditions before 11 weeks.
Sara Reardon, Kaiser Health News
Jun 27, 2022 9:07am
RNA sequencing enhances pediatric cancer diagnoses: study
Jan 28, 2022 2:13pm
Sema4 signals $623M bid for genetic testing provider GeneDx
Jan 18, 2022 9:51am
Mesa Labs bids $300M for genetic test maker Agena Bioscience
Sep 14, 2021 12:21pm
Genome Medical plots growth spurt with VC raise, acquisition
Aug 30, 2021 8:00am
NeoGenomics moves forward with $390M option to buy out Inivata
May 6, 2021 12:27pm